Abstract:Brief episodes of ischaemia and reperfusion render the heart resistant to subsequent prolonged ischaemic insult, termed ischaemic preconditioning. Here, we hypothesized that transient non-ischaemic stress by hypertrophic stimulation would induce endogenous cardioprotective signalling and enhance cardiac resistance to subsequent ischaemic damage. Transient transverse aortic constriction (TAC) or Ang-Ⅱ treatment was performed for 3-7 days in male mice and then withdrawn for several days by either aortic debanding or discontinuing Ang-Ⅱ treatment, followed by subsequent exposure to regional myocardial ischaemia by in situ coronary artery ligation. Following ischaemia/reperfusion (I/R) injury, myocardial infarct size and apoptosis were markedly reduced and contractile function was significantly improved in the TAC preconditioning group compared with that in the control group. Similar results were observed in mice receiving Ang-Ⅱ infusion. Mechanistically, TAC preconditioning enhanced ALDH2 activity, promoted AMPK activation and improved mitochondrial energy metabolism by increasing myocardial OXPHOS complex expression, elevating the mitochondrial ATP content and improving viable myocardium glucose uptake. Moreover, TAC preconditioning significantly mitigated I/R-induced myocardial iNOS/gp91phox activation, inhibited endoplasmic reticulum stress and ameliorated mitochondrial impairment. Using a pharmacological approach to inhibit AMPK signalling in the presence or absence of preconditioning, we demonstrated AMPK-dependent protective mechanisms of TAC preconditioning against I/R injury. Furthermore, treatment with adenovirus-encoded ALDH2 partially emulated the actions of hypertrophic preconditioning, as evidenced by improved mitochondrial metabolism, inhibited oxidative stress-induced mitochondrial damage and attenuated cell death through an AMPK-dependent mechanism, whereas genetic ablation of ALDH2 abrogated the aforementioned actions of TAC preconditioning. The present study demonstrates that preconditioning with hypertrophic stress protects the heart from I/R injury via mechanisms that improve mitochondrial metabolism, reduce oxidative/nitrative stress and inhibit apoptosis. ALDH2 is obligatorily required for the development of cardiac hypertrophic preconditioning and acts as the mediator of this process.

Reduction of Activin Receptor-Like Kinase 4 Expression Ameliorates Myocardial Ischemia/Reperfusion Injury Through Inhibiting TGFβ Signaling Pathway

Aliskiren Ameliorates Pressure Overload-Induced Heart Hypertrophy and Fibrosis in Mice

Partial Inhibition Of Activin Receptor-Like Kinase 4 Attenuates Pressure Overload-Induced Cardiac Fibrosis And Improves Cardiac Function

Haplodeficiency of Activin Receptor-Like Kinase 4 Alleviates Myocardial Infarction-Induced Cardiac Fibrosis and Preserves Cardiac Function

TANK-binding Kinase 1 Alleviates Myocardial Ischemia/reperfusion Injury Through Regulating Apoptotic Pathway.

Activin Receptor-Like Kinase 4 Haplodeficiency Alleviates the Cardiac Inflammation and Pacing-Induced Ventricular Arrhythmias after Myocardial Infarction.

ALK1 Deficiency Impairs the Wound-Healing Process and Increases Mortality in Murine Model of Myocardial Infarction

MRTF-A alleviates myocardial ischemia reperfusion injury via inhibiting TLR4/TRIF signaling pathways

Activin Receptor‐Like Kinase 4 Haplodeficiency Mitigates Arrhythmogenic Atrial Remodeling and Vulnerability to Atrial Fibrillation in Cardiac Pathological Hypertrophy

GW28-e0582 Activin Receptor-Like Kinase 4 Deficiency Attenuates Atrial Remodeling and Vulnerability to Atrial Fibrillation Induced by Pressure Overload in Mice

GW28-e1205 Activin Receptor-Like Kinase 4 Deficiency Attenuates Atrial Remodeling and Vulnerability to Atrial Fibrillation Induced by Pressure Overload in Mice

Thymosin β4 Protects against Cardiac Damage and Subsequent Cardiac Fibrosis in Mice with Myocardial Infarction

Protective Effect of Aliskiren in Experimental Ischemic Stroke: Up-Regulated p-PI3K, p-AKT, Bcl-2 Expression, Attenuated Bax Expression

The Effects of Therapeutic Hypothermia on the Expression of DKK3 and Myocardial Ischemia-Reperfusion Injury

TGF-β improves myocardial function and prevents apoptosis induced by anoxia-reoxygenation, through the reduction of endoplasmic reticulum stress

ALKBH5 Deletion Ameliorates Inflammation by Regulating IRF3 Signaling in an M6a-Dependent Manner after Myocardial Infarction

Protection against myocardial ischemia/reperfusion injury in TLR4-deficient mice is mediated through a phosphoinositide 3-kinase-dependent mechanism.

Abstract 238: Toll-Like Receptor 4-Deficiency Improves Ischemic Cardiomyocytes Contractile Dysfunction Via Augmentation of AMPK Activation

Effects of STAT4 on myocardial ischemia‑reperfusion injury and the underlying mechanisms

Hypertrophic Preconditioning Cardioprotection after Myocardial Ischaemia/reperfusion Injury Involves ALDH2-dependent Metabolism Modulation

The crucial role of activin A/ALK4 pathway in the pathogenesis of Ang-II-induced atrial fibrosis and vulnerability to atrial fibrillation